Compare FEMY & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEMY | INLX |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.2M | 36.5M |
| IPO Year | 2021 | N/A |
| Metric | FEMY | INLX |
|---|---|---|
| Price | $0.50 | $8.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.83 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 3.6K |
| Earning Date | 03-26-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,061,502.00 | ★ $16,539,674.00 |
| Revenue This Year | $64.02 | N/A |
| Revenue Next Year | $147.19 | $15.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 63.53 | N/A |
| 52 Week Low | $0.31 | $7.50 |
| 52 Week High | $1.80 | $15.72 |
| Indicator | FEMY | INLX |
|---|---|---|
| Relative Strength Index (RSI) | 37.70 | 45.82 |
| Support Level | $0.48 | $7.95 |
| Resistance Level | $0.54 | $8.51 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 15.19 | 23.88 |
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.